Expertise
Internationally recognized leaders in the field, PCCTC investigators come from the nation’s top academic medical centers where they are actively engaged in world class science through cutting-edge translational prostate cancer research.
THE PROSTATE CANCER CLINICAL TRIALS CONSORTIUM
The PCCTC was formed to address critically unmet needs in prostate cancer. Our mission is to design, implement, and complete early-phase process driven clinical trials, translating scientific discoveries to improved standards of care.
Recent News Phase I DSTP3086S Trial Results Published
The PCCTC is changing how prostate cancer drugs are developed. Our unique infrastructure facilitates project co-development between investigators, clinical research sites and industry partners.
Our Participating Clinical Research Sites
Recent News +++
Phase I DSTP3086S Trial Results Published
Media Relations by PCCTC November 11, 2019PCCTC study demonstrates safety and antitumor activity of humanized immunoglobulin G1 anti...
Learn MorePCCTC Investigators Drs. Rathkopf and McBride Receive Prestigious SU2C Grant
Press Releases by PCCTC October 17, 2019Award will fund novel trial using immunotherapy combined with radiation and hormone therap...
Learn MorePCCTC Germline Genetics Working Group Publishes Results
Press Releases by PCCTC July 29, 2019Study published in Clinical Genitourinary Cancer argues multidisciplinary efforts are key ...
Learn MorePCCTC Working Group Publishes Genetic Testing Manuscript
Press Releases by PCCTC April 26, 2019Investigators from the Prostate Cancer Clinical Trials Consortium (PCCTC) formed the Germl...
Learn MorePhase III DORA Study Now Enrolling Patients with mCRPC
Press Releases by PCCTC April 19, 2019The phase III DORA study (ClinicalTrials.gov Identifier: NCT03574571) led by PCCTC investi...
Learn MoreBlood Test Predicts Resistance To Hormonal Therapy
Press Releases by MedPage Today March 18, 2019AR-V7 successfully predicted resistance to hormonal therapy in advanced prostate cancer
Learn MoreFollow Us
Addition sites in the Netherlands are activating the @DoraTrial, an open-labeled, randomized, phase III study of do… https://t.co/RadtHfRWxO
Join our team of dedicated clinical research professionals! The Prostate Cancer Clinical Trials Consortium is currently seeking a Quality Manager and Clinical Data Manager to help fulfill our…
2018-23944 Clinical Data Manager, Prostate Cancer Clinical Trials Consortium (PCCTC) | Memorial Sloan Kettering Cancer Center Careers
careers.mskcc.org
Committed to world-class science!
Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.